ArticleBMC microbiology2026
Insight into the molecular characteristics of community-associated Staphylococcus aureus isolates from pediatric patients in South China.
Article in BMC microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundCommunity-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) poses a significant global public health threat. However, data on community-associated S. aureus (CA-SA) infections in children in Hainan remain scarce. This study aimed to characterize the molecular characteristics of CA-SA isolates obtained from pediatric patients at a university hospital in Hainan, the southernmost province of China.
methodsA total of 117 CA-SA isolates, including 31 MRSA and 86 methicillin-susceptible S. aureus (MSSA), were collected in Hainan between July 2023 and May 2025. These isolates were characterized using multilocus sequence typing (MLST), staphylococcal protein A (spa) typing, staphylococcal cassette chromosome mec (SCCmec) typing, and analyses of antimicrobial resistance and virulence gene profiles.
resultsEighteen distinct sequence types (STs) and 49 spa types were identified among the 117 isolates, with ST398-t011(15,12.8%) and ST22-t039(15,12.8%) being the most prevalent. ST398 and ST22 were the dominant clones among MSSA isolates, whereas ST59-SCCmec IV/V(10, 8.5%) and ST45-SCCmec IV(9,7.7%) were the predominant clones among MRSA isolates. The prevalence of CA-MRSA was 26.5%, with SCCmec types IV and V accounting for 71% and 29% of cases, respectively. All isolates exhibited susceptibility to tigecycline, teicoplanin, linezolid, and vancomycin, while 69 isolates (59.0%) were classified as multidrug-resistant (MDR). Compared to CA-MSSA strains, CA-MRSA isolates demonstrated significantly higher resistance rates to cefoxitin, oxacillin, erythromycin, clindamycin, and levofloxacin. The predominant resistance genes for erythromycin and tetracycline were ermC (77.2%, 51/66) and tetK (82.4%, 28/34), respectively. Among the 32 virulence genes tested, hla, hld, icaA, and clfA were detected in all isolates, whereas lukM was absent in all. The seb, sel, sek, and seq genes were more frequently identified in CA-MRSA isolates, while sdrD and lukE were more commonly detected in CA-MSSA isolates.
conclusionsThis study represents the first report on the molecular characteristics of CA-SA strains isolated from pediatric populations in Hainan, identifying ST398, ST22, ST59, and ST45 as the predominant genotypes. Notably, CA-MRSA epidemic strains in this region exhibit substantial molecular heterogeneity, reflecting distinct regional epidemiological patterns. These findings provide updated insights into the molecular epidemiology of S. aureus strains, offering critical reference data for clinical management and infection prevention strategies in pediatric settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.